BRIEF published on 06/27/2024 at 16:55, 4 months 23 days ago R. STAHL Shareholders Approve All Agenda Items at Annual General Meeting Annual General Meeting 2023 Financial Results R. STAHL 2024 Forecast EXcellence 2030 Strategy
PRESS RELEASE published on 06/27/2024 at 16:50, 4 months 23 days ago R. STAHL shareholders approve all agenda items at the Annual General Meeting with a clear majority R. STAHL shareholders approve all agenda items at the Annual General Meeting with a clear majority. CEO details EXcellence 2030 strategy and confirms 2024 forecasts Annual General Meeting Shareholders CEO R. STAHL Approval
BRIEF published on 06/12/2024 at 10:35, 5 months 9 days ago R. STAHL Appoints Tobias Popp as Member of Executive Board Chief Commercial Officer Executive Board R. STAHL Tobias Popp Sales Excellence
PRESS RELEASE published on 06/12/2024 at 10:30, 5 months 9 days ago R. STAHL Supervisory Board appoints Tobias Popp member of the Executive Board R. STAHL Supervisory Board appoints Tobias Popp as Chief Commercial Officer, responsible for Sales, Marketing & Portfolio and IT, effective 1 September 2024. Demonstrates continuity and strategic focus Executive Board Supervisory Board R. STAHL Tobias Popp Commercial Officer
BRIEF published on 06/11/2024 at 10:16, 5 months 10 days ago R. STAHL AG Shows Promising Growth Amid Structural Trends Growth Opportunities R. Stahl AG LNG Chemical Industry Nuclear Power
PRESS RELEASE published on 06/11/2024 at 10:11, 5 months 10 days ago Original-Research: R. STAHL AG (von NuWays AG): Kaufen Update on R. STAHL AG's operating turnaround and growth opportunities in LNG, chemical, and nuclear sectors. Analyst recommendation: Buy, Target price: EUR 29.00 R. Stahl AG LNG Chemical Industry Operating Turnaround Nuclear Sector
BRIEF published on 05/10/2024 at 09:07, 6 months 11 days ago R. Stahl AG Reports Strong Q1 2024 Performance, Maintains Optimistic FY24 Guidance Financial Guidance Stock Market R. Stahl AG Q1 2024 Performance Explosion Protection Solutions
PRESS RELEASE published on 05/10/2024 at 09:02, 6 months 11 days ago Original-Research: R. STAHL AG (von NuWays AG): Kaufen R. Stahl AG's solid final Q1 results signal continued strong demand for electrical explosion protection solutions. Management confirms FY24e guidance with good prospects for the future R. Stahl AG Q1 Results FY24e Guidance Electric Explosion Protection Solutions Prospects
BRIEF published on 05/08/2024 at 07:35, 6 months 13 days ago R. STAHL Reports Robust Financial Performance in First Quarter of 2024 EBITDA Financial Performance Order Intake R. Stahl AG Q1 2024
PRESS RELEASE published on 05/08/2024 at 07:30, 6 months 13 days ago R. STAHL sales and order intake at a high level in the first quarter of 2024 R. STAHL reports high sales and order intake in Q1 2024, with sales up 8.5% year-on-year to €84.7 million. EBITDA pre exceptionals decreased to €8.4 million. Sales expected to increase in 2024 Sales EBITDA Order Intake R. STAHL Q1 2024
Published on 11/21/2024 at 14:15, 17 minutes ago neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
Published on 11/21/2024 at 14:00, 32 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 32 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 32 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 14:16, 16 minutes ago EQS-Adhoc: LM PAY S.A. Announces Third Quarter 2024 Preliminary Results and Updated Guidance
Published on 11/21/2024 at 14:15, 17 minutes ago ZenaTech Signs Blue UAS and NDAA Compliant Supply Chain Partners to Sell to US Defense Branches and NATO Forces
Published on 11/21/2024 at 12:35, 1 hour 57 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 06:58, 7 hours 34 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 19 hours 12 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 47 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 47 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
